207 related articles for article (PubMed ID: 26334787)
1. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY
Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
3. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
5. Radiation exposure during TACE procedures using additional cone-beam CT (CBCT) for guidance: safety and precautions.
Jonczyk M; Collettini F; Geisel D; Schnapauff D; Böning G; Wieners G; Gebauer G
Acta Radiol; 2018 Nov; 59(11):1277-1284. PubMed ID: 29490465
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.
Li J; Zhou M; Liu F; Xiong C; Wang W; Cao Q; Wen X; Robertson JD; Ji X; Wang YA; Gupta S; Li C
Radiology; 2016 Nov; 281(2):427-435. PubMed ID: 27347765
[TBL] [Abstract][Full Text] [Related]
8. Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Aliberti C; Carandina R; Sarti D; Mulazzani L; Pizzirani E; Guadagni S; Fiorentini G
AJR Am J Roentgenol; 2017 Aug; 209(2):430-434. PubMed ID: 28537756
[TBL] [Abstract][Full Text] [Related]
9. Safety and Feasibility of Chemoembolization with Doxorubicin-Loaded Small Calibrated Microspheres in Patients with Hepatocellular Carcinoma: Results of the MIRACLE I Prospective Multicenter Study.
Richter G; Radeleff B; Stroszczynski C; Pereira P; Helmberger T; Barakat M; Huppert P
Cardiovasc Intervent Radiol; 2018 Apr; 41(4):587-593. PubMed ID: 29167967
[TBL] [Abstract][Full Text] [Related]
10. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
[TBL] [Abstract][Full Text] [Related]
11. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
Makary MS; Kapke J; Yildiz V; Pan X; Dowell JD
J Vasc Interv Radiol; 2016 Sep; 27(9):1298-1304. PubMed ID: 27499157
[TBL] [Abstract][Full Text] [Related]
12. Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma.
Choi JW; Kim HC; Lee JH; Yu SJ; Cho EJ; Kim MU; Hur S; Lee M; Jae HJ; Chung JW
J Vasc Interv Radiol; 2017 Jun; 28(6):795-803.e1. PubMed ID: 28302348
[TBL] [Abstract][Full Text] [Related]
13. Conventional versus Doxorubicin-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: a Tertiary Medical Centre Experience in Malaysia.
Rahman FA; Naidu J; Ngiu CS; Yaakob Y; Mohamed Z; Othman H; Jarmin R; Elias MH; Hamid NA; Mokhtar NM; Ali RR
Asian Pac J Cancer Prev; 2016; 17(8):4037-41. PubMed ID: 27644658
[TBL] [Abstract][Full Text] [Related]
14. Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization.
Morimoto M; Kobayashi S; Moriya S; Ueno M; Tezuka S; Irie K; Goda Y; Ohkawa S
Abdom Radiol (NY); 2017 Feb; 42(2):612-619. PubMed ID: 27624498
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
[TBL] [Abstract][Full Text] [Related]
16. Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
Kim SS; Nam JS; Cho HJ; Won JH; Kim JW; Ji JH; Yang MJ; Park JH; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
J Gastroenterol Hepatol; 2017 Jan; 32(1):199-207. PubMed ID: 27194671
[TBL] [Abstract][Full Text] [Related]
17. Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanoma.
Pereira PL; Krüger K; Hohenstein E; Welke F; Sommer C; Meier F; Eigentler T; Garbe C
Eur Radiol; 2018 Apr; 28(4):1456-1464. PubMed ID: 29124381
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 μm for the Treatment of Hepatocellular Carcinoma.
Sattler T; Bredt C; Surwald S; Rust C; Rieger J; Jakobs T
Anticancer Res; 2018 Feb; 38(2):1025-1032. PubMed ID: 29374736
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort.
Sandow TA; Arndt SE; Albar AA; DeVun DA; Kirsch DS; Gimenez JM; Bohorquez HE; Gilbert PJ; Thevenot PT; Nunez KG; Galliano GA; Cohen AJ; Kay D; Gulotta PM
Radiology; 2018 Mar; 286(3):1072-1083. PubMed ID: 29206595
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]